These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 14080731)

  • 1. INCREASE IN FIBRINOLYTIC ACTIVITY BY VENOUS OCCLUSION.
    HOLEMANS R
    J Appl Physiol; 1963 Nov; 18():1123-9. PubMed ID: 14080731
    [No Abstract]   [Full Text] [Related]  

  • 2. FIBRINOLYTIC AND ESTEROLYTIC ACTIVITY OF HUMAN PLASMA.
    ADAMIS DM; MANIATIS GM
    Thromb Diath Haemorrh; 1965 Jun; 13():484-91. PubMed ID: 14347870
    [No Abstract]   [Full Text] [Related]  

  • 3. [FIBRINOLYSIS INHIBITORS AND DETERMINATION OF PHYSIOLOGICAL AND PATHOLOGICAL ANTIPLASMIN ACTIVITY].
    MORIAU M; DE VRIES SI; DIK HJ
    Thromb Diath Haemorrh; 1964 Jan; 10():355-78. PubMed ID: 14113376
    [No Abstract]   [Full Text] [Related]  

  • 4. EFFECTS OF FEMALE HORMONES, USED AS ORAL CONTRACEPTIVES, ON THE FIBRINOLYTIC SYSTEM IN BLOOD.
    BRAKMAN P; ASTRUP T
    Lancet; 1964 Jul; 2(7349):10-2. PubMed ID: 14149193
    [No Abstract]   [Full Text] [Related]  

  • 5. ACTION OF THE NEW ANTI-FIBRINOLYTIC SUBSTANCE ON THE STREPTOKINASE-ACTIVATED PROTEASES (PLASMINS).
    MIHARA H
    Kobe J Med Sci; 1963 Dec; 18():169-77. PubMed ID: 14160537
    [No Abstract]   [Full Text] [Related]  

  • 6. FIBRINOLYSIS.
    ADAMIS D
    Conn Med; 1964 Sep; 28():662-7. PubMed ID: 14201318
    [No Abstract]   [Full Text] [Related]  

  • 7. [THE PROACTIVATOR OF THE FIBRINOLYTIC SYSTEM IN VENOUS BLOOD OF THE UMBILICAL CORD AND OF OLDER INFANTS].
    KUENZER W; MARKEL A
    Ann Paediatr; 1964; 202():278-84. PubMed ID: 14135039
    [No Abstract]   [Full Text] [Related]  

  • 8. ON THE SUBSTRATE CHARACTERISTICS OF 5-HYDROXYTRYPTAMINE-CERULOPLASMIN TREATED HUMAN FIBRIN EXPOSED TO FIBRINOLYTIC AGENTS.
    AUERSWALD W; BERNHEIMER H; DOLESCHEL W
    Med Pharmacol Exp Int J Exp Med; 1965; 12():81-91. PubMed ID: 14279888
    [No Abstract]   [Full Text] [Related]  

  • 9. THE EUGLOBULIN METHOD FOR ESTIMATION OF FIBRINOLYTIC ACTIVITY IN UROKINASE-ACTIVATED PLASMA, AND THE INFLUENCE OF TRASYLOL.
    BLIX S
    Scand J Clin Lab Invest; 1964; 16():198-200. PubMed ID: 14161857
    [No Abstract]   [Full Text] [Related]  

  • 10. [60 YEARS OF FIBRINOLYSIS].
    MARCHAL G
    Hemostase; 1963; 3():101-4. PubMed ID: 14050807
    [No Abstract]   [Full Text] [Related]  

  • 11. THE FIBRINOLYTIC SYSTEM IN HEALTH AND DISEASE.
    JOHNSON AJ; NEWMAN J
    Semin Hematol; 1964 Oct; 1():401-31. PubMed ID: 14225683
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of trypsin on the fibrinolytic system of normal serum treated with plasmin or streptokinase].
    GIACOMAZZI G
    Haematologica; 1962; 47():875-906. PubMed ID: 13947574
    [No Abstract]   [Full Text] [Related]  

  • 13. THE INHIBITION OF TRASYLOL OF FIBRINOLYTIC ACTIVITY ASSOCIATED WITH CARDIOVASCULAR OPERATIONS.
    TICE DA; WORTH MH; CLAUSS RH; REED GH
    Surg Gynecol Obstet; 1964 Jul; 119():71-4. PubMed ID: 14179354
    [No Abstract]   [Full Text] [Related]  

  • 14. PITFALLS IN THE THROMBOLYTIC TREATMENT OF VENOUS OCCLUSION.
    AMERY A; VERMYLEN J; MAES H; VERSTRAETE M
    Vasc Dis; 1964 Mar; 1():89-93. PubMed ID: 14186547
    [No Abstract]   [Full Text] [Related]  

  • 15. [Increase of protein hydrolysis products during fibrinolysis].
    NIEWIAROWSKI S
    Acta Physiol Pol; 1952; 3(3):375-91. PubMed ID: 13016311
    [No Abstract]   [Full Text] [Related]  

  • 16. ON THE PLASMINOGEN ACTIVATOR FORMING CAPACITY OF HUMAN PLASMA GLOBULINS REACTING WITH STREPTOKINASE.
    AUERSWALD W; DOLESCHEL W
    Med Exp Int J Exp Med; 1964; 10():179-84. PubMed ID: 14129855
    [No Abstract]   [Full Text] [Related]  

  • 17. [RESEARCH ON THE ENZYMATIC ACTIVITIES OF PLASMIN AND STREPTOKINASE].
    VAUXSAINT CYR
    Biol Med (Paris); 1963; 52():611-30. PubMed ID: 14095161
    [No Abstract]   [Full Text] [Related]  

  • 18. INHIBITION OF FIBRINOLYSIS AND FIBRINOGENOLYSIS IN MAN: COMPARISON OF EPILSON-AMINOCAPROIC AID AND KALLIKREIN INHIBITOR.
    BECK E; SCHMUTZLER R; DUCKERT F
    Thromb Diath Haemorrh; 1963 Nov; 10():106-19. PubMed ID: 14081273
    [No Abstract]   [Full Text] [Related]  

  • 19. The euglobulin method for estimation of fibrinolytic activity in streptokinase-activated plasma.
    BLIX S
    Scand J Clin Lab Invest; 1962; 14():528-32. PubMed ID: 13971659
    [No Abstract]   [Full Text] [Related]  

  • 20. FIBRINOLYSIS AND FIBRINOLYTIC AGENTS IN CLINICAL PRACTICE. (WITH SPECIAL REFERENCE TO STREPTOKINASE).
    JAMES DC; BROWSE NL
    Br J Clin Pract; 1964 Jun; 18():343-56. PubMed ID: 14169065
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.